Potent 3‐Hydroxy‐2‐Pyridine Aldoxime Reactivators of Organophosphate‐Inhibited Cholinesterases with Predicted Blood–Brain Barrier Penetration
Tamara Zorbaz(Institute for Medical Research and Occupational Health), Pierre‐Yves Renard(Centre National de la Recherche Scientifique), Romain Mougeot(Centre National de la Recherche Scientifique), Anissa Braïki(Centre National de la Recherche Scientifique), Maja Katalinić(Institute for Medical Research and Occupational Health), Julien Renou(Centre National de la Recherche Scientifique), Rachid Baati(Centre National de la Recherche Scientifique), Nikolina Maček Hrvat(Institute for Medical Research and Occupational Health), Catherine Gomez(Centre National de la Recherche Scientifique), Joel L. Sussman(Weizmann Institute of Science), Belén Pérez(Universitat Autònoma de Barcelona), Martin H. Weik(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Ludovic Jean(Centre National de la Recherche Scientifique), Zrinka Kovarik(Institute for Medical Research and Occupational Health), Guillaume Mercey(Centre National de la Recherche Scientifique), Israel Silman(Weizmann Institute of Science), Nikola Maraković(Institute for Medical Research and Occupational Health), Florian Nachon(Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques)
Cited by 69
Related Papers
Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase
|Biochemical Journal|2013|461
Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents
|Accounts of Chemical Research|2012|399
Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study
|Molecules|2017|285
Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG+ strategy
|Acta Crystallographica Section D Biological Crystallography|2005|266
Covalent Modification of Biomolecules through Maleimide-Based Labeling Strategies
|Bioconjugate Chemistry|2018|240